There is observation of platinum resistance in lung cancer A549 cells lines with high expression of ERCC1 [14], and increased clinical evidence that overexpression of ERCC1 in NSCLC inhibits platinum efficacy. This evidence concerns the gene ERCC1 and lung carcinoma.